HUMAN Diagnostics to Showcase Innovative Products at the 2023 AACC Clinical Lab Expo

HUMAN Gesellschaft für Biochemica und Diagnostica mbH, a leading global provider of in-vitro diagnostic solutions, is thrilled to announce its participation in the highly anticipated 2023 AACC Clinical Lab Expo, which will take place from July 25th to 27th in Anaheim, CA, USA.

As a prominent exhibitor, HUMAN will be located at Booth #921, where they will showcase their cutting-edge products and engage with industry professionals, researchers, and healthcare experts. The company’s presence at the expo reaffirms its commitment to delivering high-quality diagnostic solutions that contribute to advancing patient care and laboratory excellence.

Among the spotlighted products to be featured at the exhibition are:

  1. HumaCount 5D CRP: This innovative hematology analyzer provides rapid and precise measurement of C-reactive protein (CRP), a crucial biomarker for inflammation assessment. With its advanced technology and user-friendly interface, HumaCount 5D CRP delivers reliable results and enhances laboratory efficiency.
  2. HumaNex A1c Variant: HUMAN’s HumaNex A1c Variant offers a breakthrough in glycated hemoglobin (A1c) testing. This fully automated assay delivers accurate results for A1c testing, even in the presence of hemoglobin variants, ensuring reliable diabetes management and monitoring.
  3. HumaFIA: HUMAN’s HumaFIA system is a high-performance fluorescence immunoassay analyzer designed for rapid and sensitive measurement of various analytes. With its versatility and efficiency, HumaFIA facilitates precise diagnostics across a wide range of applications.

"We are excited to participate in the prestigious AACC Clinical Lab Expo and present our latest advancements in diagnostic solutions," said Thomas Roesser, Vice President International Sales. "At HUMAN, we are dedicated to developing innovative products that empower healthcare professionals to make informed decisions and improve patient outcomes."

During the event, HUMAN’s team of experts will be available to discuss the company’s comprehensive product portfolio, provide demonstrations, and answer any questions from attendees.

Don’t miss the opportunity to visit HUMAN at Booth #921 to explore their state-of-the-art products and learn more about their commitment to advancing laboratory medicine.

For more information about HUMAN and their product offerings, please visit www.human.de

To schedule a personal meeting at the AACC 2023, please contact [email=marketing@human.de ]marketing@human.de[/email]

Über die HUMAN Gesellschaft für Biochemica und Diagnostica mbH

At HUMAN, our mission is to empower laboratories to fulfill their daily challenges and implement long-term IVD projects to improve patient care. Offering a broad and comprehensive product portfolio with German quality standards, we provide reliable solutions that meet the most diverse local requirements. Worldwide service and supply capabilities as well as close cooperation with our long-standing distribution partners enable us to individually support healthcare professionals in more than 160 countries. All above has made us a recognized global player in the IVD industry over the past half century. Discover HUMAN and see how our solutions help you achieve your objectives at www.human.de

Firmenkontakt und Herausgeber der Meldung:

HUMAN Gesellschaft für Biochemica und Diagnostica mbH
Max-Planck-Ring 21
65205 Wiesbaden
Telefon: +49 (6122) 9988-0
Telefax: +49 (6122) 9988-100
http://www.human.de

Ansprechpartner:
Thomas König
Senior Manager Marketing Communications
Telefon: 061229988167
E-Mail: t.koenig@human.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel